Third Harmonic Bio, Inc. (THRD)
(Delayed Data from NSDQ)
$12.89 USD
+1.10 (9.33%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $12.89 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for Third Harmonic Bio, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | NA |
Cost Of Goods | 0 | 0 | 0 | 0 | NA |
Gross Profit | 0 | 0 | 0 | 0 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 44 | 38 | 19 | 11 | 0 |
Income After Depreciation & Amortization | -44 | -38 | -19 | -11 | 0 |
Non-Operating Income | 13 | 3 | -11 | -2 | NA |
Interest Expense | 0 | 0 | 0 | 0 | NA |
Pretax Income | -31 | -35 | -30 | -13 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -31 | -35 | -30 | -13 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -31 | -35 | -30 | -13 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -44 | -38 | -19 | -11 | 0 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | NA |
Income After Depreciation & Amortization | -44 | -38 | -19 | -11 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 39.65 | 13.43 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.78 | -2.62 | NA | NA | NA |
Diluted Net EPS (GAAP) | -0.78 | -2.62 | -7.32 | NA | NA |
Fiscal Year end for Third Harmonic Bio, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 10.71 | 11.29 | 10.41 | 10.85 | 10.71 |
Income After SG&A, R&D, and Dept/Amort Expenses | -10.71 | -11.29 | -10.41 | -10.85 | -10.71 |
Non-Operating Income | 3.15 | 3.43 | 3.56 | 3.50 | 3.16 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -7.56 | -7.86 | -6.84 | -7.34 | -7.55 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -7.56 | -7.86 | -6.84 | -7.34 | -7.55 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -7.56 | -7.86 | -6.84 | -7.34 | -7.56 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 40.56 | 40.21 | 40.21 | 39.69 | 39.57 |
Diluted EPS Before Non-Recurring Items | -0.26 | -0.20 | 0.17 | -0.19 | -0.19 |
Diluted Net EPS (GAAP) | -0.19 | -0.20 | 0.00 | -0.19 | -0.19 |